Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)
30 7월 2021 - 5:46AM
Edgar (US Regulatory)
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b)
OF THE SECURITIES EXCHANGE ACT OF 1934.
| |
Commission File Number
001-34711 |
|
Issuer: | CHINA JO-JO DRUGSTORES, INC. |
Exchange: | Nasdaq Stock Market LLC |
(Exact name of Issuer as specified in its charter, and name of
Exchange where security is listed and/or registered)
|
|
Address: | 507-513, 5th Floor, Building A Zhejiang Province, CHINA
|
Telephone number: | +1 604 682-2928 |
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
|
|
Common Stock |
(Description of class of securities)
|
|
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
|
o 17 CFR 240.12d2-2(a)(1) |
o 17 CFR 240.12d2-2(a)(2) |
x 17 CFR 240.12d2-2(a)(3) |
o 17 CFR 240.12d2-2(a)(4) |
o
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
1 |
o
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
|
|
Pursuant to the requirements for the Securities Exchange Act of 1934,
Nasdaq Stock Market LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
|
|
2021-07-29 | By | O'Neil Blake | | Senior Specialist |
Date
| | Name | | Title |
|
1 |
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
China Jo Jo Drugstores (NASDAQ:CJJD) 과거 데이터 주식 차트 부터 5월(5) 2024 으로 6월(6) 2024
China Jo Jo Drugstores (NASDAQ:CJJD) 과거 데이터 주식 차트 부터 6월(6) 2023 으로 6월(6) 2024
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] 0년 1월 6일, 2024 (1 주 전) • Edgar (US Regulatory) |
China Jo-Jo Drugstores Announces Changes to Board of Directors 0년 1월 6일, 2024 (1 주 전) • PR Newswire (US) |
Form 424B5 - Prospectus [Rule 424(b)(5)] 0년 10월 5일, 2024 (4 주 전) • Edgar (US Regulatory) |
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] 0년 10월 5일, 2024 (4 주 전) • Edgar (US Regulatory) |
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering 0년 10월 5일, 2024 (4 주 전) • PR Newswire (US) |
China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering 0년 29월 4일, 2024 (1 월 전) • PR Newswire (US) |
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement 0년 20월 3일, 2024 (3 월 전) • PR Newswire (US) |
China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split 0년 28월 2일, 2024 (3 월 전) • PR Newswire (US) |
China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement 0년 14월 12일, 2023 (6 월 전) • PR Newswire (US) |
China Jo-Jo Drugstores Announces Celebration of its 20th Anniversary 0년 8월 11일, 2023 (7 월 전) • PR Newswire (US) |
China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering 0년 26월 9일, 2023 (8 월 전) • PR Newswire (US) |
China Jo-Jo Drugstores Announced Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency 0년 17월 6일, 2023 (12 월 전) • PR Newswire (US) |
More China Jo-jo Drugstores, Inc. News Articles
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
|